Sarcopenia in cirrhosis: a systematic review
By:
References
- 1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127:990S. https://doi.org/10.1093/jn/127.5.990S.10.1093/jn/127.5.990S9164280
- 2. Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017; 36:49e64. https://doi.org/10.1016/j.clnu.2016.09.004.10.1016/j.clnu.2016.09.00427642056
- 3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010; 39:412e23. https://doi.org/10.1093/ageing/afq034.10.1093/ageing/afq034288620120392703
- 4. Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS One. 2017; 12:e0186990. https://doi.org/10.1371/journal.pone.0186990.10.1371/journal.pone.0186990565545429065187
- 5. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J et al. Inclusion of sarcopenia within MELD (MELDSarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015; 6:e102.10.1038/ctg.2015.31481625926181291
- 6. Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hep Intl. 2018; 12:377–86.2988199210.1007/s12072-018-9875-929881992
- 7. van Vugt JLA, Buettner S, Alferink LJM et al. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int. 2018; 31:165–74.10.1111/tri.1304828871624
- 8. Ha Y, Kim D, Han S et al. Sarcopenia Predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function. Cancer Res Treat. 2018; 50:843–51.10.4143/crt.2017.232605695828882021
- 9. Montano-Loza AJ. Skeletal muscle abnormalities and outcomes after liver transplantation. Liver Transpl. 2014; 20:1293–5.10.1002/lt.2399525212893
- 10. Tsien C, Davuluri G, Singh D et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology. 2015; 61:2018–29.10.1002/hep.27717444161125613922
- 11. Qiu J, Thapaliya S, Runkana A et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism. Proc Natl Acad Sci USA. 2013; 110:18162–7.10.1073/pnas.1317049110
- 12. Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016; 43:765e77. https://doi.org/10.1111/apt.13549.10.1111/apt.13549
- 13. Thapaliya S, Runkana A, McMullen MR et al. Alcohol-induced autophagy contributes to loss in skeletal muscle mass. Autophagy. 2014; 10:677–90.10.4161/auto.27918
- 14. Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012; 27:430–41.10.1111/j.1440-1746.2011.06951.x
- 15. Trovato F, Aiello F, Larocca L, Taylor-Robinson S. The role of physical activity and nutrition in the sarcopenia of cirrhosis. J Funct Morphol Kinesiol. 2016; 1:118e25. https://doi.org/10.3390/jfmk1010118.10.3390/jfmk1010118
- 16. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016; 65:1232e44. https://doi.org/10.1016/j.jhep.2016.07.040.10.1016/j.jhep.2016.07.040
- 17. Dam G, Sorensen M, Buhl M et al. Muscle metabolism, and whole blood amino acid profile in patients with liver disease. Scand J Clin Lab Invest. 2015; 75:674–80.
- 18. Loguercio C, Sava E, Marmo R, del Vecchio Blanco C, Coltorti M. Malnutrition in cirrhotic patients: anthropometric measurements as a method of assessing nutritional status. Brit J Clin Pract. 1990; 44:98–101.
- 19. Leong D, Teo K, Rangarajan S. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015; 386:266–73.10.1016/S0140-6736(14)62000-6
- 20. Erlandson MC, Lorbergs AL, Mathur S, Cheung AM. Muscle analysis using pQCT, DXA and MRI. Eur J Radiol. 2016; 85:1505-1511.10.1016/j.ejrad.2016.03.00127005009
- 21. Sergi G, Trevisan C, Veronese N, Lucato P, Manzato E. Imaging of sarcopenia. Eur J Radiol. 2016; 85:1519-1524.10.1016/j.ejrad.2016.04.00927117135
- 22. Giusto M, Lattanzi B, Albanese C et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastro Hepatol. 2015; 27:328–34.10.1097/MEG.000000000000027425569567
- 23. Dichi JB, Dichi I, Maio R et al. Wholebody protein turnover in malnourished patients with child class B and C cirrhosis on diets low to high in protein energy. Nutrition. 2001; 17:239–42.10.1016/S0899-9007(00)00567-0
- 24. 24. Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012; 27:430–41.10.1111/j.1440-1746.2011.06951.x22004479
- 25. Dasarathy S. Etiology and management of muscle wasting in chronic liver disease. Curr Opin Gastroenterol. 2016; 32:159e65. https://doi.org/10.1016/j.coviro.2015.09.001 [Human].10.1016/j.coviro.2015.09.001[]
- 26. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016; 65:1232e44. https://doi.org/10.1016/j.jhep.2016.07.040.10.1016/j.jhep.2016.07.040511625927515775
- 27. Kawaguchi T, Taniguchi E, Sata M. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Nutr Clin Pract. 2013; 28:580e8. https://doi.org/10.1177/.
- 28. Gluud LL, Dam G, Les I, Cordoba J, Marchesini G, Borre M et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD001939.10.1002/14651858.CD00193912804416
- 29. Moctezuma-Velazquez C, Low G, Mourtzakis M et al. Association between low testosterone levels and sarcopenia in cirrhosis: a cross-sectional study. Ann Hepatol. 2018; 17:615–23.10.5604/01.3001.0012.093029893704
- 30. Lang CH, Frost RA, Svanberg E, Vary TC. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol fed rats. Am J Physiol Endocrinol Metab. 2004; 286:E916–26.10.1152/ajpendo.00554.200314749210
Language: English
Page range: 125 - 129
Published on: Feb 1, 2020
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2020 Ovidiu Paul Calapod, Andreea Maria Marin, Laura Carina Tribus, Carmen Fierbinţeanu-Braticevici, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.